We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App




TianLong HPV Nucleic Acid Detection Kit Could Enable Early Detection of Cervical Cancer

By LabMedica International staff writers
Posted on 02 Feb 2024
Print article
Image: Tianlong’s HPV detection kit covers 18 high-risk HPV types (Photo courtesy of TianLong)
Image: Tianlong’s HPV detection kit covers 18 high-risk HPV types (Photo courtesy of TianLong)

Cervical cancer is the second most common cancer after breast cancer to affect women aged 15–44 years in the European Union. Each year, there are around 33 000 cases of cervical cancer in the EU, and 15,000 deaths. The primary cause of cervical cancer is a persistent infection of the genital tract by some specific types of human papillomavirus (HPV). HPV is present in most cases of cervical lesions, which can further develop into cancer.

Vaccination rates and the incidence of cervical adenocarcinoma are both on the rise, making HPV genotype testing an important tool to help stratify risk and guide patient management. High-risk HPV genotypes 16, 18 account for 70% of cervical cancer worldwide. Tianlong’s Human Papillomavirus (HPV) Nucleic Acid Detection Kit is a qualitative in vitro test for detection of 18 high-risk HPV types (HPV 16,18,26,31,33,35,39,45,51,52,53,56,58,59,66,68,73 and 82), which can specifically identify types of HPV 16 and HPV 18 while concurrently detecting the rest of other high-risk types.

Features

  • High Precision:
  • The coefficient of variation of the Ct values (CV%) is less than 5%
  • More accurate:
  • Collocating with Tianlong extraction reagent makes your experiment results more accurate
  • Internal Control:
  • The use of internal control system in the kit can effectively prevent false negative results
  • User-friendly:
  • Applicable in instruments with FAM, HEX/VIC,CY5 and TEXAS RED/ROX channels
  • Concurrently detects remaining 16 HPV genotypes:
  • 26,31,33,35,39,45,51,52,53,56,58,59,66,68,73,82 Positive or Negative Pooled Result


About TianLong

TianLong Science and Technology Co., Ltd.(Shaanxi, China) is a Chinese manufacturer dedicated to molecular diagnosis instruments and kits for over 26 years, with IS013485, CE certificated, providing integrated PCR lab solutions and OEM service.

For more information or inquiries, please contact Tianlong team directly.  

 

Gold Member
Troponin T QC
Troponin T Quality Control
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Malaria Rapid Test
ASSURE Malaria P.f/P.v Rapid Test
New
Human Chorionic Gonadotropin Test
Humasis hCG Combo

Print article

Channels

Immunology

view channel
Image: Example image of the high-throughput microscopy method used in the study, showing immune cells stained with different fluorescence markers (Photo courtesy of Felix Kartnig/CeMM, MedUni Vienna)

Cutting-Edge Microscopy Technology Enables Tailored Rheumatology Therapies

Rheumatoid arthritis is the most common inflammatory joint disorder, with women three times as likely to suffer from the condition as men. Treatment advances made over the past decades have led to the... Read more

Microbiology

view channel
Image: RNA sequencing directly from whole blood aims to expand access to LRTI testing (Photo courtesy of CARB-X)

Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood

Pneumonia and lower-respiratory-tract infections (LRTIs) are among the top causes of illness and death globally, particularly in vulnerable populations such as the elderly, young children, and immunocompromised... Read more

Pathology

view channel
Image: Lunit SCOPE HER2 is an AI-powered solution designed to detect HER2 expression profile (Photo courtesy of Lunit)

AI-Powered Pathology Solutions Accurately Predict Outcomes for HER2-Targeted Therapy in Metastatic CRC

A new study has highlighted how artificial intelligence (AI)-powered analysis of HER2 and the tumor microenvironment (TME) can improve patient stratification and predict clinical outcomes more effectively.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.